Peter Hendricks

Peter S. Hendricks is an established researcher whose work sits at the intersection of epidemiology, behavioural science and psychedelic research. He has led and co‑authored multiple population‑based analyses examining associations between lifetime classic psychedelic use and outcomes such as psychological distress, suicidality, hypertension, cardiometabolic markers and other indices of physical health. Hendricks' portfolio includes investigations of microdosing practices, surveys of MDMA/ecstasy use and health, and methodologically careful assessments of potential harms, including case analyses of long‑term negative psychological responses.

Hendricks' contributions emphasise rigorous secondary analyses of large survey datasets, cross‑disciplinary collaboration, and transparent reporting of both potential benefits and risks of psychedelic use. He has supervised and co‑authored work that informs clinical and public health perspectives on psychedelics, and has engaged with broader field questions such as researcher identity and the ethics of contemporary psychedelic science. His scholarship has helped shape debates about population‑level effects of classic psychedelics and clarified priorities for prospective clinical and mechanistic research.